Wednesday, July 18, 2018
 
 
Company News: Page (1) of 1 - 07/12/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Rain Forest International, Inc. Commences Trading Under its New Trading Symbol
 
(July 12, 2018)

CHINCHA ALTA, Peru, July 12, 2018 /PRNewswire/ -- Rain Forest International, Inc. (the "Company") (OTC: RFII), formerly GVCL Ventures, Inc. (OTC: GVCL), announced today that the Company has gone through the mandatory period with a "D" on its former symbol and now trades under the symbol RFII. The Company's new Cusip number is 75080F101.

The Company consummated a Share Exchange Agreement with Rain Forest Nutraceuticals, Inc., a private corporation organized under the laws of the State of Nevada ("Rain Forest").  In accordance with the terms of the SEA, the Company acquired 100% of Rain Forest's shares in exchange for the issuance by the Company of 150,000,000 post reverse stock split shares of its restricted common stock (the "SEA") to the shareholders of Rain Forest resulting in Rain Forest becoming the wholly owned subsidiary of the Company.

The Company has effected a one for two hundred (1:200) reverse stock split and Gerald Neziol has resigned as the sole Director and President/Secretary/Treasurer and has appointed Jose Veliz as the sole Director and President/Secretary/Treasurer.  Rain Forest entered into a master license agreement with UVdA S.A.C., a Peruvian third generation family business ("UVdA"), pursuant to which UVdA granted to Rain Forest an exclusive worldwide license and associated rights, excluding South America, to market and sell a line of nutraceutical products based on UVdA's exceptional amazon rain forest grape seed extracts and oils (the "Products").  UVdA is a successful company producing the premium Products with revenues in excess of $1,000,000 and net profits in excess of $400,000 in their last fiscal year.



Jose Veliz, President of the Company, states, "My team and I look forward to duplicating and surpassing the great results my family achieved in South America, to the rest of the world."

About Rain Forest International, Inc.:

Rain Forest International, Inc. (www.rainforestinternational.com), is a business opportunity company with a primary focus on working with and/or acquiring operational companies to work with for the purpose of enhancing shareholder value.  Through its wholly owned subsidiary Rain Forest Nutraceuticals, Inc., it markets and sells a line of nutraceutical products based on a premium grape seed extract from the Amazon Rain Forest.

Forward Looking Statements
Undue reliance should not be placed on forward looking statements in this press release.  This press release contains forward looking statements that involve risks and uncertainties.  Words such as "will", "anticipates", "believes", "plans", "goal", "expects", "future", "intends", and similar expressions are used to identify these forward looking statements.  Actual results could materially differ from those anticipated in these forward looking statements for many reasons.

 

Cision View original content:http://www.prnewswire.com/news-releases/rain-forest-international-inc-commences-trading-under-its-new-trading-symbol-300680235.html

SOURCE Rain Forest International, Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords: Inc.,Business,Family,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Robotics Prosthetics Market Exclusive Analysis by MRFR | Industry Growing with 9.5% CAGR up to 2027 | The Demand for Robotic Prosthetic is Found to be Increasing across the Globe
  • Implantable Medical Devices Market Predicted to be Worth US$ 49.8 Bn by 2024, Says TMR
  • Global Cosmetic Chemicals Industry
  • HMP's 8th Annual Amputation Prevention Symposium Expected to Draw 800 Clinicians to Chicago to Join the CLI Revolution

    Cancer
  • Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid use Disorder
  • Omega-3 Market to Reach US$ 16.37 Bn by 2023, Globally - QYResearch.com
  • Association of Community Cancer Centers and Advisory Board Launch 9th Annual Trends in Cancer Care Survey
  • Small Animal Imaging Market is Estimated to Grow at a Faster Pace With the Significant CAGR During the Forecast Period: Radiant Insights, Inc.
  • Presage Biosciences Closes Series D Financing with Takeda and Celgene, and Announces Appointment of Richard Klinghoffer, PhD as Chief Executive Officer
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines